Robot vs. laparoscopic surgery for stomach cancer after chemo
Part of Cancer, Digestive system clinical trials.
This trial compares robotic and laparoscopic surgery for stomach cancer patients who have already received chemotherapy or targeted therapy. It aims to see which approach leads to better outcomes after neoadjuvant (pre-surgery) treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have a type of stomach cancer called adenocarcinoma (like tubular, papillary, or signet ring cell).
- Your cancer is stage II or III before any treatment, confirmed by scans or laparoscopy.
- You have completed 2 to 4 cycles of neoadjuvant therapy (chemotherapy with or without targeted/immunotherapy).
- You are fit for surgery (radical gastrectomy) after a team discussion.
- Your general health is good (ECOG score 0/1 or Karnofsky ≥70%) and your expected survival is over 6 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares robot-assisted surgery to standard laparoscopic surgery for people with stage Ib, II, or III stomach cancer. It aims to see which approach leads to better recovery and outcomes.
This phase 3 trial compares robot-assisted surgery to standard laparoscopic surgery for treating stomach cancer that has grown through the stomach wall (cT4a) but not spread to distant organs. The goal is to see which approach may offer better outcomes.
This trial tests whether using a robotic arm to remove stomach cancer is safe and effective for patients who have already received chemotherapy or radiation. If you have stage III stomach cancer and are healthy enough for surgery, this approach may offer a more precise operation.
This trial compares robotic-assisted surgery to standard laparoscopic surgery for locally advanced stomach cancer. It aims to see which approach offers better outcomes and recovery for patients.
This trial compares robotic and laparoscopic surgery to remove the whole stomach for certain “locally advanced” cancers in the middle or upper stomach. It aims to see which approach is safer and more effective, including how completely the cancer can be removed.
This trial compares a newer, less invasive robotic surgery with the standard laparoscopic approach for removing part of the stomach in people with early-stage gastric cancer. It aims to see if the robotic method offers better recovery or outcomes.
Hear when a new Gastric Cancer Stage III trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.